As 3M Co (MMM) Share Price Rose, Acropolis Investment Management Has Cut by $401,907 Its Holding; As Heron Therapeutics (Call) (HRTX) Stock Price Declined, Holder Kingdon Capital Management Has Lowered Stake by $10.58 Million

February 20, 2018 - By Nellie Frank

Mark Kingdon decreased its stake in Heron Therapeutics Inc (Call) (HRTX) by 61.45% based on its latest 2017Q3 regulatory filing with the SEC. Kingdon Capital Management Llc sold 661,500 shares as the company’s stock declined 1.40% while stock markets rallied. The hedge fund run by Mark Kingdon held 415,000 shares of the health care company at the end of 2017Q3, valued at $6.70 million, down from 1.08 million at the end of the previous reported quarter. Kingdon Capital Management Llc who had been investing in Heron Therapeutics Inc (Call) for a number of months, seems to be less bullish one the $1.54 billion market cap company. The stock decreased 0.42% or $0.1 during the last trading session, reaching $23.8. About 526,358 shares traded. Heron Therapeutics, Inc. (NASDAQ:HRTX) has declined 20.92% since February 20, 2017 and is downtrending. It has underperformed by 37.62% the S&P500.

Acropolis Investment Management Llc decreased its stake in 3M Co (MMM) by 15.76% based on its latest 2017Q3 regulatory filing with the SEC. Acropolis Investment Management Llc sold 1,923 shares as the company’s stock rose 7.02% with the market. The institutional investor held 10,280 shares of the medical and dental instruments company at the end of 2017Q3, valued at $2.16M, down from 12,203 at the end of the previous reported quarter. Acropolis Investment Management Llc who had been investing in 3M Co for a number of months, seems to be less bullish one the $140.94B market cap company. The stock increased 0.77% or $1.8 during the last trading session, reaching $236.67. About 2.22M shares traded. 3M Company (NYSE:MMM) has risen 18.59% since February 20, 2017 and is uptrending. It has outperformed by 1.89% the S&P500.

Among 13 analysts covering Heron Therapeutics (NASDAQ:HRTX), 13 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Heron Therapeutics had 33 analyst reports since August 3, 2015 according to SRatingsIntel. On Thursday, August 3 the stock rating was maintained by Cowen & Co with “Buy”. The firm has “Buy” rating given on Thursday, June 1 by Aegis Capital. The rating was initiated by Aegis Capital with “Buy” on Wednesday, October 26. The stock of Heron Therapeutics, Inc. (NASDAQ:HRTX) earned “Buy” rating by Brean Capital on Monday, August 10. The stock of Heron Therapeutics, Inc. (NASDAQ:HRTX) has “Buy” rating given on Tuesday, September 26 by Mizuho. The stock of Heron Therapeutics, Inc. (NASDAQ:HRTX) has “Buy” rating given on Monday, June 12 by Jefferies. On Tuesday, November 7 the stock rating was maintained by Mizuho with “Buy”. On Friday, November 10 the stock rating was maintained by Oppenheimer with “Buy”. The rating was maintained by Oppenheimer on Thursday, December 14 with “Buy”. The stock of Heron Therapeutics, Inc. (NASDAQ:HRTX) earned “Buy” rating by Lake Street on Thursday, December 10.

Analysts await Heron Therapeutics, Inc. (NASDAQ:HRTX) to report earnings on February, 22. They expect $-0.82 earnings per share, up 32.79% or $0.40 from last year’s $-1.22 per share. After $-0.77 actual earnings per share reported by Heron Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 6.49% negative EPS growth.

Kingdon Capital Management Llc, which manages about $3.27B and $1.53 billion US Long portfolio, upped its stake in Ferroglobe Plc by 199,768 shares to 299,670 shares, valued at $3.94M in 2017Q3, according to the filing. It also increased its holding in Centene Corp Del (NYSE:CNC) by 49,595 shares in the quarter, for a total of 151,632 shares, and has risen its stake in Clovis Oncology Inc (NASDAQ:CLVS).

Acropolis Investment Management Llc, which manages about $912.87 million and $611.34M US Long portfolio, upped its stake in Vanguard Scottsdale Fds (VMBS) by 30,769 shares to 712,813 shares, valued at $37.62 million in 2017Q3, according to the filing. It also increased its holding in Ishares Tr (IJH) by 6,730 shares in the quarter, for a total of 508,376 shares, and has risen its stake in Vanguard Index Fds.

Investors sentiment decreased to 0.77 in 2017 Q3. Its down 0.14, from 0.91 in 2017Q2. It is negative, as 59 investors sold MMM shares while 612 reduced holdings. 101 funds opened positions while 417 raised stakes. 387.06 million shares or 0.01% more from 387.02 million shares in 2017Q2 were reported. Crestwood Advisors Group Inc Ltd reported 1.34% stake. Ibm Retirement Fund holds 14,339 shares. 75,364 were accumulated by Ngam Limited Partnership. New York State Teachers Retirement has 0.52% invested in 3M Company (NYSE:MMM). Wealth Architects Ltd Liability Corporation owns 17,167 shares. New York-based Cv Starr Communications Inc Tru has invested 5.84% in 3M Company (NYSE:MMM). 1,500 are held by Copeland Cap Management Limited Liability Corporation. Sawgrass Asset Mgmt Ltd invested in 129,447 shares or 1.33% of the stock. Cs Mckee Lp has 71,160 shares for 1.16% of their portfolio. Marshwinds Advisory Co owns 20,335 shares or 1.98% of their US portfolio. Franklin Street Nc reported 0.19% stake. Guardian Life Ins Of America owns 1,357 shares. Bluefin Trading Llc stated it has 0.04% of its portfolio in 3M Company (NYSE:MMM). Warren Averett Asset Mgmt Ltd Liability holds 0.31% or 6,789 shares in its portfolio. Moreover, Ray Gerald L & Limited has 0.2% invested in 3M Company (NYSE:MMM).

Among 16 analysts covering 3M (NYSE:MMM), 7 have Buy rating, 4 Sell and 5 Hold. Therefore 44% are positive. 3M had 79 analyst reports since July 24, 2015 according to SRatingsIntel. Bank of America maintained 3M Company (NYSE:MMM) rating on Wednesday, October 25. Bank of America has “Buy” rating and $257 target. The stock has “Hold” rating by Stifel Nicolaus on Friday, January 26. The firm has “Buy” rating by Citigroup given on Wednesday, October 25. JP Morgan downgraded 3M Company (NYSE:MMM) on Wednesday, September 20 to “Underweight” rating. RBC Capital Markets maintained the shares of MMM in report on Monday, July 10 with “Hold” rating. On Thursday, December 14 the stock rating was maintained by Jefferies with “Buy”. The rating was maintained by Stifel Nicolaus with “Hold” on Wednesday, July 19. Jefferies maintained the shares of MMM in report on Monday, May 29 with “Buy” rating. The rating was maintained by Jefferies on Monday, August 14 with “Buy”. The firm has “Hold” rating by RBC Capital Markets given on Tuesday, December 12.

Since October 27, 2017, it had 0 insider buys, and 20 insider sales for $33.77 million activity. Shares for $419,846 were sold by Gangestad Nicholas C on Thursday, February 1. $56,178 worth of stock was sold by Vrohidis Ippocratis on Thursday, February 1. The insider THULIN INGE G sold 18,866 shares worth $4.75M. Keel Paul A sold $3.33 million worth of stock. $1.68 million worth of 3M Company (NYSE:MMM) shares were sold by Shin Hak Cheol. Fong Ivan K also sold $547,377 worth of 3M Company (NYSE:MMM) on Friday, October 27.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>